ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 694620 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 694620; 2) Community: the network communities that were significantly associated with the response to NSC 694620; 3) Molecule: the relationships between components within communities and NSC 694620; 4) MDR: the compounds that were significantly associated with the NSC 694620.

NSC Compound Enrichment Correlation
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0193573267900282 -0.093964528
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0193573267900282 0.060113287
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0203119150246194 0.31644849
NSC 100290 Doxypyrromycin hydrochloride 0.0209467683758286 -0.21051161
NSC 116878 Cardiac glycoside 0.0209467683758286 0.0048546692
NSC 125845 Null 0.0209467683758286 -0.16993784
NSC 134754 Null 0.0209467683758286 -0.13718992
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 0.0209467683758286 -0.13071683
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0209467683758286 -0.25421753
NSC 243022 Cinerubin A hydrochloride 0.0209467683758286 -0.13375334
Total:100  Current:47    [First] [Prev] [Next] [Last]